Form 8-K - Current report:
SEC Accession No. 0001558370-23-011384
Filing Date
2023-06-23
Accepted
2023-06-23 16:15:33
Documents
16
Period of Report
2023-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20230621x8k.htm   iXBRL 8-K 67589
2 EX-10.1 fbio-20230621xex10d1.htm EX-10.1 2646
3 EX-10.2 fbio-20230621xex10d2.htm EX-10.2 8137
  Complete submission text file 0001558370-23-011384.txt   331522

Data Files

Seq Description Document Type Size
4 EX-101.SCH fbio-20230621.xsd EX-101.SCH 4623
5 EX-101.DEF fbio-20230621_def.xml EX-101.DEF 14890
6 EX-101.LAB fbio-20230621_lab.xml EX-101.LAB 3326
7 EX-101.PRE fbio-20230621_pre.xml EX-101.PRE 14865
10 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20230621x8k_htm.xml XML 7218
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 231037850
SIC: 2834 Pharmaceutical Preparations